Cell-matrix talks: Effects on differentiation of hepatocellular carcinoma

Minerva Gastroenterologica e Dietologica

Volumn 52, Issue 4, 2006, Pages 407-413

  Wu, X Z ^a,c   Chen, D ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b SOUTHWEST MEDICAL UNIVERSITY   (China)

^c KEY LABORATORY OF CANCER PREVENTION AND THERAPY   (China)

Author keywords

Adhesion; Extracellular matrix; Hepatocellular carcinoma; Integrin

Indexed keywords

ALBUMIN; ALPHA INTERFERON; BETA CATENIN; BUTYRIC ACID; CATENIN; INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEAR FACTOR; PROTEIN P53; RETINOIC ACID; TRANSCRIPTION FACTOR; UVOMORULIN; WNT PROTEIN;

ARTICLE; CELL INTERACTION; CELL PROLIFERATION; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

CADHERINS; CARCINOMA, HEPATOCELLULAR; CATENINS; CELL ADHESION; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; DOWN-REGULATION; EXTRACELLULAR MATRIX; FORECASTING; HEPATOCYTES; INTEGRINS; LIVER CIRRHOSIS; LIVER NEOPLASMS; PHENOTYPE; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 33846535314     PISSN: 00264776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Bissell DM. Chronic liver injury, TGF-beta, and cancer. Exp Mol Med 2001;33:179-90.
2. Boudreau N, Bissell MJ. Extracellular matrix signaling: integration of form and function in normal and malignant cells. Curr Opin Cell Biol 1998;10:640-6.
3. Tennenbaum T, Belanger AJ, Quaranta V, Yuspa SH. Differential regulation of integrins and extracellular matrix binding in epidermal differentiation and squamous tumor progression. J Investig Dermatol Symp Proc 1996;1:157-61.
4. Sugimoto S, Mitaka T, Ikeda S, Harada K, Ikai I, Yamaoka Y et al. Morphological changes induced by extracellular matrix are correlated with maturation of rat small hepatocytes. J Cell Biochem 2002;87:16-28.
5. Nagaki M, Shidoji Y, Yamada Y, Sugiyama A, Tanaka M, Akaike T et al. Regulation of hepatic genes and liver transcription factors in rat hepatocytes by extracellular matrix. Biochem Biophys Res Commun 1995;210:38-43.
6. Brill S, Zvibel I, Halpern Z, Oren R. The role of fetal and adult hepatocyte extracellular matrix in the regulation of tissue-specific gene expression in fetal and adult hepatocytes. Eur J Cell Biol 2002;81:43-50.
7. Hayashi Y, Wang W, Ninomiya T, Nagano H, Ohta K, Itoh H. Liver enriched transcription factors and differentiation of hepatocellular carcinoma. Mol Pathol 1999;52:19-24.
8. Jackson DA, Rowader KE, Stevens K, Jiang C, Milos P, Zaret KS. Modulation of liver-specific transcriptions between hepatocyte nuclear factor 3 and nuclear factor 1 binding DNA in close apposition. Mol Cell Biol 1993;13:2401-10.
9. Kuo CJ, Conley PB, Chen L, Sladek FM, Darnell JE Jr, Crabtree GR. A transcriptional hierarchy involved in mammalian cell type specification. Nature 1992;355:457-61.
10. DiPersio CM, Jackson DA, Zaret KS. The extracellular matrix coordinately modulates liver transcription factors and hepatocyte morphology. Mol Cell Biol 1991;11:4405-14.
11. Caron JM. Induction of albumin gene transcription in hepatocytes by extracellular matrix proteins. Mol Cell Biol 1990;10:1239-43.
12. Sidhu JS, Liu F, Omiecinski CJ. Phenobarbital responsiveness as a uniquely sensitive indicator of hepatocyte differentiation status: requirement of dexamethasone and extracellular matrix in establishing the functional integrity of cultured primary rat hepatocytes. Exp Cell Res 2004;292:252-64.
13. Rana B, Mischoulon D, Xie Y, Bucher NL, Farmer SR. Cell-extracellular matrix interactions can regulate the switch between growth and differentiation in rat hepatocytes: reciprocal expression of C/EBP alpha and immediate-early growth response transcription factors. Mol Cell Biol 1994;14:5858-69.
14. Shachaf CM, Kopelman AM, Arvanitis C, Karlsson A, Beer S, Mandl S et al. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 2004;431:1112-7.
15. Grigioni WF, Garbisa S, D'Errico A, Baccarini P, Stetler-Stevenson WG, Liotta LA et al. Evaluation of hepatocellular carcinoma aggressiveness by a panel of extracellular matrix antigens. Am J Pathol 1991;138:647-54.
16. Torimura T, Ueno T, Inuzuka S, Kin M, Ohira H, Kimura Y et al. The extracellular matrix in hepatocellular carcinoma shows different localization patterns depending on the differentiation and the histological pattern of tumors: immunohistochemical analysis. J Hepatol 1994;21:37-46.
17. Lewalle JM, Szpirer C, Szpirer J, Munaut C, Foidart JM. Rat chromosome 5 (q22-23) contains elements that control cell morphology and interactions with the extracellular matrix: a study of normal fibroblast x malignant hepatoma cell hybrids. Exp Cell Res 1991;196:164-71.
18. Fujii M, Yamashita Y, Shirabe K, Ijima H, Nakazawa K, Funatsu K et al. Basic study about the development of the hybrid-artificial liver support system using human hepatoma cell lines (Hep G2, Huh 7): effects on liver functions by extracellular matrix (type I collagen) in monolayer culture. Fukuoka Igaku Zasshi 2001;92:299-305.
19. Zhao M, Laissue JA, Zimmermann A. Tenascin and type IV collagen expression in liver cell dysplasia and in hepatocellular carcinoma. Histol Histopathol 1996;11:323-33.
20. Kudriavtseva EI, Morozova OV, Rudinskaia TD, Engel'gard NV. [Disruption of intercellular contacts and cell-extracellular matrix interaction in rapidly growing murine hepatocarcinoma] Arkh Patol 2001;63:33-7. Russian.
21. Tsang KJ, Crowe DL. Retinoic acid and extracellular matrix inhibition of matrix metalloproteinase 9 expression is mediated by the mitogen activated protein kinase pathway. Int J Oncol 2001;18:369-74.
22. Kojima J, Nakamura N, Kanatani M, Akiyama M. Glycosaminoglycans in 3'-methyl-4-dimethylaminoazobenzene-induced rat hepatic cancer. Cancer Res 1982;42:2857-60.
23. Robinson J, Viti M, Hook M. Structure and properties of an under-sulfated heparan sulfate proteoglycan synthesized by a rat hepatoma cell line. J Cell Biol 1984;98:946-53.
24. Zvibel I, Halay E, Reid LM. Heparin and hormonal regulation of mRNA synthesis and abundance of autocrine growth factors: relevance to clonal growth of tumors. Mol Cell Biol 1991;11:108-16.
25. Jemth P, Kreuger J, Kusche-Gullberg M, Sturiale L, Gimenez-Gallego G, Lindahl U. Biosynthetic oligosaccharide libraries for identification of protein-binding heparan sulfate motifs. Exploring the structural diversity by screening for fibroblast growth factor (FGF)1 and FGF2 binding. J Biol Chem 2002;277:30567-73.
26. Mazure NM, Nguyen TL, Danan JL. Severe hypoxia specifically downregulates hepatocyte nuclear factor-4 gene expression in HepG2 human hepatoma cells. Tumour Biol 2001;22:310-7.
27. Boudreau NJ, Jones PL. Extracellular matrix and integrin signalling: the shape of things to come. Biochem J 1999;339:481-8.
28. Jaskiewicz K, Chasen MR, Robson SC. Differential expression of extracellular matrix proteins and integrins in hepatocellular carcinoma and chronic liver disease. Anticancer Res 1993;13:2229-37.
29. Seebacher T, Medina JL, Bade EG. Laminin alpha 5, a major transcript of normal and malignant rat liver epithelial cells, is differentially expressed in developing and adult liver. Exp Cell Res 1997;237:70-6.
30. Szendroi M, Lapis K. Distribution of fibronectin and laminin in human liver tumors. J Cancer Res Clin Oncol 1985;109:60-4.
31. Yao M, Zhou XD, Zha XL, Shi DR, Fu J, He JY et al. Expression of the integrin alpha5 subunit and its mediated cell adhesion in hepatocellular carcinoma. J Cancer Res Clin Oncol 1997;123:435-40.
32. Lai E, Prezioso VR, Tao WF, Chen WS, Darnell JE Jr. Hepatocyte nuclear factor 3 alpha belongs to a gene family in mammals that is homologous to the Drosophila homeotic gene fork head. Genes Dev 1991;5:416-27.
33. Lai E, Prezioso VR, Tao WF, Chen WS, Darnell JE Jr. Modulation of liver-specific transcriptions between hepatocyte nuclear factor 3 and nuclear factor 1 binding DNA in close apposition. Mol Cell Biol 1993;13:2401-10.
34. Feng Y, Wang LY, Cai T, Jin JW, Zhou GF, Cao LH et al. All-trans-retinoic acid increased the expression of integrin alpha5beta1 and induced "anoikis" in SMMC-7721 hepatocarcinoma cell. J Exp Clin Cancer Res 2001;20:429-38.
35. Nusse R. Relay at the membrane. Nature 2005;438:747-9.
36. Cadigan KM, Nasse R. Wint signaling: a common theme in animal development. Genes Dev 1997;11:3286-305.
37. Colnot S, Decaens T, Niwa-Kawakita M, Godard C, Hamard G, Kahn A et al. Liver-targeted disruption of Ape in mice activates beta-catenin signaling and leads to hepatocellular carcinomas. Proc Natl Acad Sci U S A 2004;101:17216-21.
38. Ishizaki Y, Ikeda S, Fujimori M, Shimizu Y, Kurihara T, Itamoto T et al. Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas. Int J Oncol 2004;24:1077-83.
39. Ikenoue T, Ijichi H, Kato N, Kanai F, Masaki T, Rengifo W et al. Analysis of the beta-catenin/T cell factor signaling pathway in 36 gastrointestinal and liver cancer cells. Jpn J Cancer Res 2002;93:1213-20.
40. Lee HC, Kim M, Wands JR. Wnt/frizzled signaling in hepatocellular carcinoma. Front Biosci 2006;11:1901-15.
41. Suzuki T, Yano H, Nakashima Y, Nakashima O, Kojiro M. Beta-catenin expression in hepatocellular carcinoma: a possible participation of beta-catenin in the dedifferentiation process. J Gastroenterol Hepatol 2002;17:994-1000.
42. Asayama Y, Taguchi Ki K, Aishima Si S, Nishi H, Masuda K, Tsuneyoshi M. The mode of tumour progression in combined hepatocellular carcinoma and cholangiocarcinoma: an immunohistochemical analysis of E-cadherin, alpha-catenin and beta-catenin. Liver 2002;22:43-50.
43. Ihara A, Koizumi H, Hashizume R, Uchikoshi T. Expression of epithelial cadherin and alpha- and beta-catenins in nontumoral livers and hepatocellular carcinomas. Hepatology 1996;23:1441-7.
44. Choi YL, Park SH, Jang JJ, Park CK. Expression of the G1-S modulators in hepatitis B virus-related hepatocellular carcinoma and dysplastic nodule: association of cyclin D1 and p53 proteins with the progression of hepatocellular carcinoma. J Korean Med Sci 2001;16:424-32.
45. Naka T, Toyota N, Kaneko T, Kaibara N. Protein expression of p53, p21WAF1, and Rb as prognostic indicators in patients with surgically treated hepatocellular carcinoma. Anticancer Res 1998;18:555-64.
46. Cagatay T, Ozturk M. P53 mutation as a source of aberrant beta-catenin accumulation in cancer cells. Oncogene 2002;21:7971-80.
47. Giles RH, van Es JH, Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 2003;1653:1-24.
48. Calvisi DF, Conner EA, Ladu S, Lemmer ER, Factor VM, Thorgeirsson SS. Activation of the canonical Wnt/beta-catenin pathway confers growth advantages in c-Myc/E2F1 transgenic mouse model of liver cancer. J Hepatol 2005;42:842-9.
49. Jung HC, Kim K. Identification of MYCBP as a beta-catenin/LEF-1 target using DNA microarray analysis. Life Sci 2005;77:1249-62.
50. Calvisi DF, Ladu S, Conner EA, Factor VM, Thorgeirsson SS. Disregulation of E-cadherin in transgenic mouse models of liver cancer. Lab Invest 2004;84:1137-47.
51. Hayashida Y, Honda K, Idogawa M, Ino Y, Ono M, Tsuchida A et al. E-cadherin regulates the association between beta-catenin and actinin-4. Cancer Res 2005;65:8836-45.
52. Noe V, Chastre E, Bruyneel E, Gespach C, Marcel M. Extracellular regulation of cancer invasion: the E-cadherin-catenin and other pathways. Biochem Soc Symp 1999;65:43-62.
53. Masuda T, Saito H, Kaneko F, Atsukawa K, Monta M, Inagaki H et al. Up-regulation of E-cadherin and I-catenin in human hepatocellular carcinoma cell lines by sodium butyrate and interferon-alpha. In Vitro Cell Dev Biol Anim 2000;36:387-94.
54. Kozyraki R, Scoazec JY, Flejou JF, D'Errico A, Bedossa P, Terris B et al. Expression of cadherins and alpha-catenin in primary epithelial tumors of the liver. Gastroenterology 1996;110:1137-49.
55. Zhao M, Laissue JA, Zimmermann A. Tenascin and type IV collagen expression in liver cell dysplasia and in hepatocellular carcinoma. Histol Histopathol 1996;11:323-33.
56. Jaskiewicz K, Chasen MR, Robson SC. Differential expression of extracellular matrix proteins and integrins in hepatocellular carcinoma and chronic liver disease. Anticancer Res 1993;13:2229-37.
57. Ruiz C, Huang W, Hegi ME, Lange K, Hamou MF, Fluri E et al. Growth promoting signaling by tenascin-C. Cancer Res 2004;64:7377-85.
58. Beiter K, Hiendlmeyer E, Brabletz T, Hlubek F, Haynl A, Knoll C et al. beta-catenin regulates the expression of tenascin-C in human colorectal tumors. Oncogene 2005;24:8200-4.
59. Oloumi A, McPhee T, Dedhar S. Regulation of E-cadherin expression and beta-catenin/Tcf transcriptional activity by the integrin-linked kinase. Biochim Biophys Acta 2004;1691:1-15.